Kelyniam Global, Inc. Stock Other OTC
Equities
KLYG
US4883591004
Advanced Medical Equipment & Technology
Sales 2022 | 3.02M 4.12M | Sales 2023 | 2.67M 3.65M | Capitalization | 1.83M 2.49M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 0.99 x |
Net Debt 2022 | 560K 764K | Net Debt 2023 | 623K 850K | EV / Sales 2023 | 0.92 x |
P/E ratio 2022 |
-24.8
x | P/E ratio 2023 |
-8.35
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53.55% |
Managers | Title | Age | Since |
---|---|---|---|
Ross Bjella
CEO | Chief Executive Officer | - | 18-01-08 |
Director of Finance/CFO | - | 20-01-31 | |
Chief Operating Officer | - | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | - | 10-12-31 | |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 14-05-31 |
Ross Bjella
CEO | Chief Executive Officer | - | 18-01-08 |
1st Jan change | Capi. | |
---|---|---|
+9.02% | 219B | |
+7.41% | 183B | |
+11.20% | 133B | |
+25.41% | 108B | |
+0.27% | 63.06B | |
+12.50% | 52.02B | |
-0.62% | 48.2B | |
+0.08% | 40.37B | |
+13.43% | 39.35B |